US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Sionna Therapeutics

7.93

+0.31004.07%

Volume:137.15K

Turnover:1.08M

Market Cap:356.83M

PE:-3.66

High:7.96

Open:7.79

Low:7.66

Close:7.62

52wk High:54.97

52wk Low:4.01

Shares:45.00M

Float Shares:16.73M

Volume Ratio:2.95

T/O Rate:0.82%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.1683

EPS(LYR):-1.8835

ROE:-32.34%

ROA:-21.54%

PB:1.34

PE(LYR):-4.21

Loading ...

Overview Company News Filings

Sionna Therapeutics to attend Raymond James Biotech Innovation Symposium investor meetings

Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation Symposium

A Look At Sionna Therapeutics (SION) Valuation After A 166% One Year Share Price Gain

Simply Wall St.

Three new option listings on March 17th

Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (SION) and Health Catalyst (HCAT)

Analysts Offer Insights on Healthcare Companies: GH Research (GHRS) and Sionna Therapeutics, Inc. (SION)

Sionna Therapeutics Chief Legal Officer Jennifer Fitzpatrick Disposes of Common Shares

Sionna Therapeutics price target raised to $50 from $45 at Guggenheim

Sionna Therapeutics Price Target Maintained With a $58.00/Share by BTIG

BRIEF-Sionna Therapeutics Inc Maintains Strong Cash Position With About $310.3 Million In Cash And Cash Equivalents, Expected To Fund Operations Into 2028

Sionna Therapeutics files automatic mixed securities shelf

Sionna Therapeutics Inc: Files for Mixed Shelf Offering; Size Not Disclosed - SEC Filing

THOMSON REUTERS

Sionna Therapeutics Q4 EPS $(0.46) Beats $(0.55) Estimate

Benzinga Earnings

Earnings Flash (SION) Sionna Therapeutics Posts Q4 Net Loss $0.46 a Share, vs. FactSet Est of $0.55 Loss

MT Newswires Live

Sionna Therapeutics reports smaller-than-expected Q4 net loss

Sionna posts FY 2025 net loss of USD 75.3 million, cash and marketable securities USD 310.3 million up 84.7%

Sionna Therapeutics Inc: Maintains Strong Cash Position With About $310.3 Mln in Cash and Cash Equivalents, Expected to Fund Operations Into 2028

THOMSON REUTERS

Sionna Therapeutics Inc Q4 Basic EPS USD -0.46

THOMSON REUTERS

Sionna Therapeutics Inc Q4 Net Income USD -20.44 Million VS. Ibes Estimate USD -24.6 Million

THOMSON REUTERS

Press Release: Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/SION/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"SION","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SION\",,,,,undefined,":{"symbol":"SION","market":"US","secType":"STK","nameCN":"Sionna Therapeutics","latestPrice":7.93,"timestamp":1789134417238,"preClose":7.62,"halted":0,"volume":137150,"delay":0,"changeRate":0.04068241469816268,"floatShares":16725500,"shares":44998073,"eps":-2.16827,"marketStatus":"Trading","change":0.31,"latestTime":"09-11 09:47:01 EDT","open":7.79,"high":7.96,"low":7.6565,"amount":1078103.59059,"amplitude":0.039829,"askPrice":7.94,"askSize":644,"bidPrice":7.86,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-2.16827,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789156800000},"marketStatusCode":2,"adr":0,"listingDate":1738904400000,"exchange":"NASDAQ","adjPreClose":7.62,"preHourTrading":{"tag":"盘前","latestPrice":7.57,"preClose":7.62,"latestTime":"09:27 EDT","volume":795,"amount":6063.8598765,"timestamp":1789133228270,"change":-0.05,"changeRate":-0.006562,"amplitude":0.028871},"postHourTrading":{"tag":"盘后","latestPrice":7.64,"preClose":7.62,"latestTime":"19:30 EDT","volume":18381,"amount":139913.3744,"timestamp":1789083007612,"change":0.02,"changeRate":0.002625,"amplitude":0.027559},"volumeRatio":2.945133,"impliedVol":1.4566,"impliedVolPercentile":0.4597},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SION\",,,,,undefined,":{"symbol":"SION","floatShares":16725500,"roa":"-21.54%","roe":"-32.34%","lyrEps":-1.883481,"volumeRatio":2.945133,"shares":44998073,"dividePrice":0,"high":7.96,"amplitude":0.039829,"preClose":7.62,"low":7.6565,"week52Low":4.01,"pbRate":"1.34","week52High":54.97,"institutionHeld":0,"latestPrice":7.93,"committee":-0.993808,"eps":-2.16827,"divideRate":0,"volume":137150,"delay":0,"ttmEps":-2.16827,"open":7.79,"prevYearClose":41.14,"prevWeekClose":7.18,"prevMonthClose":6.03,"prevQuarterClose":43.99,"fiveDayClose":6.75,"twentyDayClose":6.54,"sixtyDayClose":34.75},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SION\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"SION","fiscalQuarterEnding":"2026/06","expectedEps":-0.64,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":-0.66},{"market":"US","date":"2026-05-12","symbol":"SION","fiscalQuarterEnding":"2026/03","expectedEps":-0.52,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"pre","actualEps":-0.6},{"market":"US","date":"2026-03-02","symbol":"SION","fiscalQuarterEnding":"2025/12","expectedEps":-0.61,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772427600000,"reportTimeType":"pre","actualEps":-0.46},{"market":"US","date":"2025-11-05","symbol":"SION","fiscalQuarterEnding":"2025/09","expectedEps":-0.52,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"pre","actualEps":-0.46},{"market":"US","date":"2025-08-11","symbol":"SION","fiscalQuarterEnding":"2025/06","expectedEps":-0.68,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-0.41}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SION\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SION\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.0909,"hold":0.9091,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.9091,"analysts":11,"updateTime":1786420800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SION\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SION","date":"2026-09-10","current":-3.657294,"percent":0.947236,"low":-28.087165,"twenty":-23.978528,"median":-18.336633,"eighty":-9.914959,"high":-2.089233,"avg":-17.257455,"sd":7.157819,"marketCap":338188744},"quantilePoints":[{"date":"2025-02-07","current":-13.261013,"twenty":-12.252025,"median":-10.738543,"eighty":-9.22506,"marketCap":765372600},{"date":"2025-02-14","current":-14.940741,"twenty":-16.115077,"median":-14.940741,"eighty":-13.535074,"marketCap":862319796},{"date":"2025-02-21","current":-15.365065,"twenty":-15.365065,"median":-14.763927,"eighty":-14.631317,"marketCap":886810118},{"date":"2025-02-28","current":-11.280197,"twenty":-15.101402,"median":-14.760244,"eighty":-13.045594,"marketCap":651047865},{"date":"2025-03-07","current":-11.960372,"twenty":-15.059369,"median":-14.631317,"eighty":-11.310767,"marketCap":690304817},{"date":"2025-03-14","current":-13.068521,"twenty":-15.036515,"median":-13.072343,"eighty":-11.387191,"marketCap":754262771},{"date":"2025-03-21","current":-10.607665,"twenty":-14.940741,"median":-12.594692,"eighty":-11.280197,"marketCap":612232003},{"date":"2025-03-28","current":-8.569094,"twenty":-14.763927,"median":-12.189644,"eighty":-10.607665,"marketCap":528610240},{"date":"2025-04-04","current":-8.304439,"twenty":-14.75656,"median":-11.44833,"eighty":-8.654927,"marketCap":512284214},{"date":"2025-04-11","current":-5.47907,"twenty":-14.719724,"median":-11.345158,"eighty":-8.304439,"marketCap":337992858},{"date":"2025-04-17","current":-7.152833,"twenty":-14.648998,"median":-11.146455,"eighty":-7.438946,"marketCap":441243940},{"date":"2025-04-25","current":-9.012569,"twenty":-13.535074,"median":-10.607665,"eighty":-7.830921,"marketCap":555967364},{"date":"2025-05-02","current":-9.227154,"twenty":-13.113134,"median":-10.157913,"eighty":-8.049798,"marketCap":569204682},{"date":"2025-05-09","current":-8.991111,"twenty":-13.07005,"median":-9.363058,"eighty":-8.189398,"marketCap":554643632},{"date":"2025-05-16","current":-8.935031,"twenty":-13.050179,"median":-9.227154,"eighty":-8.189398,"marketCap":592598052},{"date":"2025-05-23","current":-8.649163,"twenty":-12.684872,"median":-9.227154,"eighty":-8.258154,"marketCap":573638442},{"date":"2025-05-30","current":-9.380453,"twenty":-12.498397,"median":-9.212848,"eighty":-8.290133,"marketCap":622139770},{"date":"2025-06-06","current":-10.656886,"twenty":-12.42503,"median":-9.227154,"eighty":-8.395596,"marketCap":706796635},{"date":"2025-06-13","current":-11.295102,"twenty":-12.251212,"median":-9.28738,"eighty":-8.459628,"marketCap":749125067},{"date":"2025-06-20","current":-9.792634,"twenty":-12.067794,"median":-9.313972,"eighty":-8.462287,"marketCap":649476883},{"date":"2025-06-27","current":-9.859115,"twenty":-11.920631,"median":-9.377129,"eighty":-8.491142,"marketCap":653886095},{"date":"2025-07-03","current":-14.087299,"twenty":-12.050418,"median":-9.569923,"eighty":-8.540482,"marketCap":934311959},{"date":"2025-07-11","current":-13.921097,"twenty":-12.562594,"median":-9.646376,"eighty":-8.576247,"marketCap":923288929},{"date":"2025-07-18","current":-12.185946,"twenty":-12.955414,"median":-9.792431,"eighty":-8.606288,"marketCap":808208504},{"date":"2025-07-25","current":-12.724441,"twenty":-12.981363,"median":-9.952188,"eighty":-8.61201,"marketCap":843923119},{"date":"2025-08-01","current":-11.142196,"twenty":-12.981363,"median":-10.527086,"eighty":-8.61201,"marketCap":738983880},{"date":"2025-08-08","current":-11.487897,"twenty":-12.719123,"median":-10.607665,"eighty":-8.619441,"marketCap":761911781},{"date":"2025-08-15","current":-12.17004,"twenty":-12.719123,"median":-10.776552,"eighty":-8.650316,"marketCap":922963698},{"date":"2025-08-22","current":-13.817157,"twenty":-12.981363,"median":-10.951574,"eighty":-8.660649,"marketCap":1047879398},{"date":"2025-08-29","current":-14.969557,"twenty":-13.185819,"median":-11.135548,"eighty":-8.685971,"marketCap":1135276247},{"date":"2025-09-05","current":-13.421384,"twenty":-13.261013,"median":-11.264381,"eighty":-8.6957,"marketCap":1017864318},{"date":"2025-09-12","current":-13.849168,"twenty":-13.582045,"median":-11.295102,"eighty":-8.81229,"marketCap":1050307088},{"date":"2025-09-19","current":-13.520327,"twenty":-13.543608,"median":-11.380538,"eighty":-8.928383,"marketCap":1025368088},{"date":"2025-09-26","current":-16.005553,"twenty":-13.817157,"median":-11.448008,"eighty":-8.935031,"marketCap":1213845132},{"date":"2025-10-03","current":-17.053189,"twenty":-13.934393,"median":-11.481249,"eighty":-8.974919,"marketCap":1293296813},{"date":"2025-10-10","current":-16.50027,"twenty":-14.087299,"median":-11.594266,"eighty":-8.991111,"marketCap":1251363982},{"date":"2025-10-17","current":-19.043698,"twenty":-14.329335,"median":-11.773765,"eighty":-9.012569,"marketCap":1444255008},{"date":"2025-10-24","current":-23.047996,"twenty":-14.678547,"median":-11.960372,"eighty":-9.101233,"marketCap":1747936990},{"date":"2025-10-31","current":-22.122584,"twenty":-14.777491,"median":-12.128534,"eighty":-9.127014,"marketCap":1677754672},{"date":"2025-11-07","current":-21.722088,"twenty":-15.059369,"median":-12.17004,"eighty":-9.148473,"marketCap":1535230307},{"date":"2025-11-14","current":-22.656643,"twenty":-15.557397,"median":-12.201274,"eighty":-9.173508,"marketCap":1601280913},{"date":"2025-11-21","current":-24.588899,"twenty":-16.50027,"median":-12.318908,"eighty":-9.207602,"marketCap":1737845004},{"date":"2025-11-28","current":-27.51254,"twenty":-16.690008,"median":-12.434201,"eighty":-9.211799,"marketCap":1944476293},{"date":"2025-12-05","current":-25.813923,"twenty":-17.070649,"median":-12.542534,"eighty":-9.224293,"marketCap":1824424853},{"date":"2025-12-12","current":-26.344347,"twenty":-17.43383,"median":-12.644664,"eighty":-9.227154,"marketCap":1861913035},{"date":"2025-12-19","current":-27.916672,"twenty":-18.615331,"median":-12.828464,"eighty":-9.244321,"marketCap":1973038717},{"date":"2025-12-26","current":-27.799853,"twenty":-20.840976,"median":-13.015231,"eighty":-9.271873,"marketCap":1964782391},{"date":"2026-01-02","current":-25.978102,"twenty":-21.880226,"median":-13.072343,"eighty":-9.298017,"marketCap":1836028338},{"date":"2026-01-09","current":-23.111292,"twenty":-22.280894,"median":-13.196456,"eighty":-9.333606,"marketCap":1633413640},{"date":"2026-01-16","current":-24.532068,"twenty":-22.755262,"median":-13.25865,"eighty":-9.367357,"marketCap":1733828413},{"date":"2026-01-23","current":-26.375919,"twenty":-23.010449,"median":-13.309024,"eighty":-9.375135,"marketCap":1864144474},{"date":"2026-01-30","current":-26.798995,"twenty":-23.217376,"median":-13.467945,"eighty":-9.407045,"marketCap":1894045762},{"date":"2026-02-06","current":-22.258826,"twenty":-24.10394,"median":-13.562826,"eighty":-9.536018,"marketCap":1573164777},{"date":"2026-02-13","current":-23.768006,"twenty":-23.957443,"median":-13.817157,"eighty":-9.627762,"marketCap":1679827580},{"date":"2026-02-20","current":-23.578569,"twenty":-24.004802,"median":-13.914449,"eighty":-9.63308,"marketCap":1666438943},{"date":"2026-02-27","current":-23.99533,"twenty":-24.004802,"median":-13.951438,"eighty":-9.646376,"marketCap":1695893944},{"date":"2026-03-06","current":-20.661282,"twenty":-23.99533,"median":-14.087299,"eighty":-9.713547,"marketCap":1555133402},{"date":"2026-03-13","current":-21.928699,"twenty":-23.824837,"median":-14.227481,"eighty":-9.792228,"marketCap":1650529317},{"date":"2026-03-20","current":-21.217272,"twenty":-23.768006,"median":-14.329335,"eighty":-9.792634,"marketCap":1596981610},{"date":"2026-03-27","current":-22.693932,"twenty":-23.692231,"median":-14.628741,"eighty":-9.859115,"marketCap":1708126851},{"date":"2026-04-02","current":-24.690711,"twenty":-23.779372,"median":-14.699136,"eighty":-9.933573,"marketCap":1858420414},{"date":"2026-04-10","current":-23.249921,"twenty":-23.779372,"median":-14.763927,"eighty":-10.393622,"marketCap":1749975058},{"date":"2026-04-17","current":-27.046193,"twenty":-23.997224,"median":-14.955149,"eighty":-10.519675,"marketCap":2035712822},{"date":"2026-04-24","current":-22.927089,"twenty":-24.052712,"median":-15.059369,"eighty":-10.529177,"marketCap":1725676099},{"date":"2026-05-01","current":-23.210503,"twenty":-24.014274,"median":-15.233234,"eighty":-10.592246,"marketCap":1747008171},{"date":"2026-05-08","current":-25.975372,"twenty":-24.255396,"median":-15.761105,"eighty":-10.607665,"marketCap":1955114312},{"date":"2026-05-15","current":-22.568569,"twenty":-24.314473,"median":-16.442494,"eighty":-10.647042,"marketCap":1931079614},{"date":"2026-05-22","current":-22.030343,"twenty":-24.255396,"median":-16.587573,"eighty":-10.662204,"marketCap":1885026277},{"date":"2026-05-29","current":-22.584399,"twenty":-24.225568,"median":-16.843662,"eighty":-10.799155,"marketCap":1932434124},{"date":"2026-06-05","current":-19.935481,"twenty":-24.091149,"median":-17.056099,"eighty":-10.92148,"marketCap":1705779467},{"date":"2026-06-12","current":-19.022607,"twenty":-24.014274,"median":-17.123032,"eighty":-10.948046,"marketCap":1627669396},{"date":"2026-06-18","current":-19.381425,"twenty":-24.010485,"median":-17.425682,"eighty":-10.97603,"marketCap":1658371620},{"date":"2026-06-26","current":-22.568569,"twenty":-24.001013,"median":-17.729808,"eighty":-11.059188,"marketCap":1931079614},{"date":"2026-07-02","current":-21.972299,"twenty":-23.989729,"median":-17.973475,"eighty":-11.131559,"marketCap":1880059741},{"date":"2026-07-10","current":-23.713619,"twenty":-23.938829,"median":-18.418073,"eighty":-11.16347,"marketCap":2029055830},{"date":"2026-07-17","current":-23.898305,"twenty":-23.898305,"median":-18.702419,"eighty":-11.254892,"marketCap":2044858445},{"date":"2026-07-24","current":-23.249267,"twenty":-23.989729,"median":-18.996224,"eighty":-11.281848,"marketCap":1989323539},{"date":"2026-07-31","current":-24.684537,"twenty":-24.004802,"median":-19.043698,"eighty":-11.288454,"marketCap":2112132437},{"date":"2026-08-07","current":-23.001015,"twenty":-24.109374,"median":-19.37351,"eighty":-11.295102,"marketCap":2239907871},{"date":"2026-08-14","current":-3.036352,"twenty":-24.014274,"median":-19.249507,"eighty":-11.248566,"marketCap":295689089},{"date":"2026-08-21","current":-2.562793,"twenty":-24.014274,"median":-19.009416,"eighty":-10.951574,"marketCap":249572442},{"date":"2026-08-28","current":-2.813501,"twenty":-24.004802,"median":-18.741047,"eighty":-10.656886,"marketCap":273987137},{"date":"2026-09-04","current":-3.13385,"twenty":-23.99533,"median":-18.500988,"eighty":-10.523599,"marketCap":305183693},{"date":"2026-09-10","current":-3.47277,"twenty":-23.978528,"median":-18.336633,"eighty":-9.914959,"marketCap":338188744}],"updateTime":1789134421404},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SION\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2625932965","title":"Sionna Therapeutics to attend Raymond James Biotech Innovation Symposium investor meetings","url":"https://stock-news.laohu8.com/highlight/detail?id=2625932965","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625932965?lang=en_us&edition=fundamental","pubTime":"2026-04-07 19:06","pubTimestamp":1775560012,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics management to hold one-on-one investor meetings at Raymond James 2026 Biotech Innovation Symposium on April 14, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sionna Therapeutics Inc. published the original content used to generate this news brief on April 07, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nNDL8BbhCc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2265009873.SGD","BK4139","LU1363072403.SGD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","SION","IE00B64PRP62.GBP","LU1804176565.USD","BK4588","BK4585","RJF","BK4127","LU0971096721.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625471932","title":"Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2625471932","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625471932?lang=en_us&edition=fundamental","pubTime":"2026-04-07 19:00","pubTimestamp":1775559600,"startTime":"0","endTime":"0","summary":"WALTHAM, Mass., April  07, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm fo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/07/3268961/0/en/Sionna-Therapeutics-to-Participate-in-the-Raymond-James-2026-Biotech-Innovation-Symposium.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1363072403.SGD","SION","BK4139","BK4588","IE00B64PRP62.GBP","BK4093","BK4127","RJF","XBI","CF","LU2265009873.SGD","LU0971096721.USD","IE00BGHQF748.EUR","BK4585","BK4581","IE00B3QW5Z07.USD","LU1804176565.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621718054","title":"A Look At Sionna Therapeutics (SION) Valuation After A 166% One Year Share Price Gain","url":"https://stock-news.laohu8.com/highlight/detail?id=2621718054","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621718054?lang=en_us&edition=fundamental","pubTime":"2026-03-22 11:09","pubTimestamp":1774148958,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics (SION) is back in focus for investors after recent trading left the shares with a return of about 166% over the past year, contrasting with weaker near term moves.\nSee our latest analysis for Sionna Therapeutics.\nThe share price is currently US$36.39, and short term share price returns over 1 and 3 months have been weak, yet the 1 year total shareholder return of about 166% points to strong earlier momentum that has recently cooled.\nIf you are looking beyond a single...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sion/sionna-therapeutics/news/a-look-at-sionna-therapeutics-sion-valuation-after-a-166-one","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sion/sionna-therapeutics/news/a-look-at-sionna-therapeutics-sion-valuation-after-a-166-one","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SION","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620142296","title":"Three new option listings on March 17th","url":"https://stock-news.laohu8.com/highlight/detail?id=2620142296","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620142296?lang=en_us&edition=fundamental","pubTime":"2026-03-17 20:36","pubTimestamp":1773750987,"startTime":"0","endTime":"0","summary":"New option listings for March 17th include GBank Financial Holdings Inc (GBFH), Oculis Holding AG (OCS), and Sionna Therapeutics Inc (SION). Publis...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/three-new-option-listings-on-march-17th-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/three-new-option-listings-on-march-17th-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SION","BK4139","GBFH","BK4211","BK4007","OCS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619115004","title":"Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (SION) and Health Catalyst (HCAT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2619115004","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619115004?lang=en_us&edition=fundamental","pubTime":"2026-03-13 22:40","pubTimestamp":1773412805,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Sionna Therapeutics, Inc. (SION – Research Report) and Health Cat...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sionna-therapeutics-inc-sion-and-health-catalyst-hcat-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sionna-therapeutics-inc-sion-and-health-catalyst-hcat-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4585","XLV","BK4588","BK4581","SION","LU0128526141.USD","HCAT","XBI","LABU","HCSG","BK4137","LU0029874061.USD","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617204659","title":"Analysts Offer Insights on Healthcare Companies: GH Research (GHRS) and Sionna Therapeutics, Inc. (SION)","url":"https://stock-news.laohu8.com/highlight/detail?id=2617204659","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617204659?lang=en_us&edition=fundamental","pubTime":"2026-03-07 09:50","pubTimestamp":1772848211,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on GH Research (GHRS – Research Report) and Sionna Ther...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-gh-research-ghrs-and-sionna-therapeutics-inc-sion-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-gh-research-ghrs-and-sionna-therapeutics-inc-sion-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","GHRS","HCSG","GH","LU0128526141.USD","BK4539","BK4585","BK4588","BK4535","BK4137","LABU","BK4007","XBI","SION","LU0029874061.USD","BK4196","BK4551","BK4139","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617892656","title":"Sionna Therapeutics Chief Legal Officer Jennifer Fitzpatrick Disposes of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2617892656","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617892656?lang=en_us&edition=fundamental","pubTime":"2026-03-07 07:56","pubTimestamp":1772841395,"startTime":"0","endTime":"0","summary":"Jennifer Fitzpatrick, Chief Legal Officer of Sionna Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sionna Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 06, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nNDL8z08VR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Sionna Therapeutics Chief Legal Officer Jennifer Fitzpatrick Disposes of Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616347359","title":"Sionna Therapeutics price target raised to $50 from $45 at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2616347359","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616347359?lang=en_us&edition=fundamental","pubTime":"2026-03-03 20:19","pubTimestamp":1772540385,"startTime":"0","endTime":"0","summary":"Guggenheim raised the firm’s price target on Sionna Therapeutics (SION) to $50 from $45 and keeps a Buy rating on the shares after the company anno...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sionna-therapeutics-price-target-raised-to-50-from-45-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sionna-therapeutics-price-target-raised-to-50-from-45-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616335745","title":"Sionna Therapeutics Price Target Maintained With a $58.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2616335745","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616335745?lang=en_us&edition=fundamental","pubTime":"2026-03-03 01:52","pubTimestamp":1772473920,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SION/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 02, 2026 12:52 ET (17:52 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616745358","title":"BRIEF-Sionna Therapeutics Inc Maintains Strong Cash Position With About $310.3 Million In Cash And Cash Equivalents, Expected To Fund Operations Into 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2616745358","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616745358?lang=en_us&edition=fundamental","pubTime":"2026-03-02 22:16","pubTimestamp":1772460961,"startTime":"0","endTime":"0","summary":"BRIEF-Sionna Therapeutics Inc Maintains Strong Cash Position With About $310.3 Million In Cash And Cash Equivalents, Expected To Fund Operations Into 2028March 2 (Reuters) - Sionna Therapeutics Inc SI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nTUA1VBCBZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616330996","title":"Sionna Therapeutics files automatic mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2616330996","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616330996?lang=en_us&edition=fundamental","pubTime":"2026-03-02 21:34","pubTimestamp":1772458492,"startTime":"0","endTime":"0","summary":"08:21 EST Sionna Therapeutics (SION) files automatic mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-m...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sionna-therapeutics-files-automatic-mixed-securities-shelf-thefly-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sionna-therapeutics-files-automatic-mixed-securities-shelf-thefly-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SION","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616371783","title":"Sionna Therapeutics Inc: Files for Mixed Shelf Offering; Size Not Disclosed - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2616371783","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616371783?lang=en_us&edition=fundamental","pubTime":"2026-03-02 21:22","pubTimestamp":1772457763,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nFWN3ZQ0QY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616479331","title":"Sionna Therapeutics Q4 EPS $(0.46) Beats $(0.55) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2616479331","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616479331?lang=en_us&edition=fundamental","pubTime":"2026-03-02 20:19","pubTimestamp":1772453974,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics Q4 EPS $(0.46) Beats $(0.55) Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/50961161/sionna-therapeutics-q4-eps-0-46-beats-0-55-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616533141","title":"Earnings Flash (SION) Sionna Therapeutics Posts Q4 Net Loss $0.46 a Share, vs. FactSet Est of $0.55 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2616533141","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616533141?lang=en_us&edition=fundamental","pubTime":"2026-03-02 20:15","pubTimestamp":1772453742,"startTime":"0","endTime":"0","summary":"Earnings Flash (SION) Sionna Therapeutics Posts Q4 Net Loss $0.46 a Share, vs. FactSet Est of $0.55 Loss","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616331180","title":"Sionna Therapeutics reports smaller-than-expected Q4 net loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2616331180","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616331180?lang=en_us&edition=fundamental","pubTime":"2026-03-02 20:11","pubTimestamp":1772453492,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics reports smaller-than-expected Q4 net lossOverviewBiopharmaceutical firm reports  Q4 net loss of -$20.44 mlnCompany maintains strong cash position, expected to fund operations into ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nL1N3ZQ0ID:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616331858","title":"Sionna posts FY 2025 net loss of USD 75.3 million, cash and marketable securities USD 310.3 million up 84.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616331858","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616331858?lang=en_us&edition=fundamental","pubTime":"2026-03-02 20:02","pubTimestamp":1772452933,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics reported a Q4 net loss of USD 20.4 million and a FY net loss of USD 75.3 million. Q4 R&D expenses were USD 15.2 million  and Q4 G&A expenses were USD 8.4 million . For FY 2025, R&D expenses were USD 60.3 million  and G&A expenses were USD 28.7 million . Cash, cash equivalents and marketable securities totaled USD 310.3 million as of Dec. 31, 2025, which the company expects will fund operations into 2028. On the business front, Sionna said its PreciSION CF Phase 2a proof-of-concept trial of NBD1 stabilizer SION-719 as an add-on to standard of care remains on track, with topline data anticipated in mid-2026. The company also said its Phase 1 trial evaluating SION-451 in proprietary dual combinations with SION-2222 and with SION-109 in healthy volunteers is ongoing, with topline data also anticipated in mid-2026. CEO Mike Cloonan said Sionna delivered positive results from two Phase 1 trials of SION-719 and SION-451, and the company highlighted that both were generally","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDL4VLDxh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","BK4139","BK4112","IE00BKPKM429.USD","NDAQ","IE00BGHQF748.EUR","BK4588","SION","IE00B64PRP62.GBP","SG9999014039.USD","LU0314104364.USD","BK4585","LU2210149790.SGD","LU2210150020.SGD","SG9999014013.SGD","SG9999014005.SGD","SG9999014021.USD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616331564","title":"Sionna Therapeutics Inc: Maintains Strong Cash Position With About $310.3 Mln in Cash and Cash Equivalents, Expected to Fund Operations Into 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2616331564","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616331564?lang=en_us&edition=fundamental","pubTime":"2026-03-02 20:00","pubTimestamp":1772452804,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nTUA1VBCBZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616339732","title":"Sionna Therapeutics Inc Q4 Basic EPS USD -0.46","url":"https://stock-news.laohu8.com/highlight/detail?id=2616339732","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616339732?lang=en_us&edition=fundamental","pubTime":"2026-03-02 20:00","pubTimestamp":1772452802,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nPLX616D77:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SION","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616339723","title":"Sionna Therapeutics Inc Q4 Net Income USD -20.44 Million VS. Ibes Estimate USD -24.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2616339723","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616339723?lang=en_us&edition=fundamental","pubTime":"2026-03-02 20:00","pubTimestamp":1772452802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nPLX616D77:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616392303","title":"Press Release: Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2616392303","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616392303?lang=en_us&edition=fundamental","pubTime":"2026-03-02 20:00","pubTimestamp":1772452800,"startTime":"0","endTime":"0","summary":"Ongoing PreciSION CF Phase 2a proof-of-concept trial evaluating NBD1 stabilizer SION-719 as an add-on to standard of care in participants with cystic fibrosis is on track with topline data anticipated in mid-2026. Maintained strong cash position with approximately $310.3 million in cash and cash equivalents, expected to fund operations into 2028. \"2025 was a remarkable and transformative year for Sionna. Propelled by the momentum of our upsized IPO in February, we have been steadily executing across our pipeline and strengthening the capabilities of our team. We delivered positive results from the two Phase 1 trials of our first-in-class NBD1 stabilizers SION-719 and SION-451 and expeditiously advanced these candidates into the next stages of development,\" said Mike Cloonan, President and Chief Executive Officer of Sionna. \"With topline readouts from both of our ongoing trials anticipated this year, along with the capital to support us into 2028, Sionna is making meaningful progress to","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","BK4588","BK4093","SION","SOC","PK","CF","BK4218","BK4139","BK4181","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":6,"totalSize":125,"code":"91000000","status":"200"}]}}